Brain Stimulation for Essential Tremor
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests new methods of delivering brain stimulation to assist individuals with Essential Tremor (ET). Researchers aim to determine if modifying the software in existing devices can safely and effectively reduce tremors. Participants will experiment with different settings on their brain stimulation devices, such as Active biphasic pulse stimulation, to identify the most effective option. This trial may suit individuals who already have a brain stimulator for ET but continue to experience worsening tremors. As an unphased trial, it offers participants the chance to explore innovative treatment options that could enhance their quality of life.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on brain stimulation for Essential Tremor, so it's best to ask the study team for guidance.
What prior data suggests that these brain stimulation techniques are safe for Essential Tremor patients?
Research has shown that active biphasic pulse stimulation is a safe treatment for people with Essential Tremor (ET). In one study, seven patients received this treatment for a week and reported no negative effects. Another study with ten participants also found the treatment safe and easy to handle, with no serious side effects. These results suggest that the treatment is generally well-tolerated in humans, based on current research.12345
Why are researchers excited about this trial?
Researchers are excited about this treatment for essential tremor because it uses active biphasic pulse stimulation, a novel approach compared to the usual continuous deep brain stimulation (DBS). Unlike standard DBS, this method involves different stimulation settings, including a "Home" setting, a "VIN Biphasic" setting, and a "Stimulator Off" period, allowing for personalized adjustments based on patient response. The innovative aspect is the temporary custom firmware that enables these varied stimulation patterns, potentially offering more effective tremor control and improved quality of life for patients who haven't fully benefited from traditional DBS.
What evidence suggests that this trial's treatments could be effective for Essential Tremor?
Research has shown that a new method called active biphasic pulse stimulation may help treat Essential Tremor (ET). In this trial, participants will experience different conditions of this stimulation: Home Settings, VIN Biphasic, and Stimulator Off. Studies have found that this type of stimulation can ease symptoms in ET patients by widening the range of effective treatment, potentially making it more effective than standard options. One study found that biphasic stimulation is safe and can significantly reduce symptoms. Compared to other deep brain stimulation methods, biphasic pulses can offer similar or even better improvements. These findings suggest that biphasic stimulation could be a helpful treatment for people with ET.12467
Who Is on the Research Team?
Joshua K Wong, MD
Principal Investigator
Univeristy of Florida
Are You a Good Fit for This Trial?
This trial is for people with Essential Tremor who already have a brain stimulation device implanted. They should be mentally sharp (with an MMSE score over 24) and have noticed their tremor control isn't as good as it was after surgery, even on two different check-ups.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive active biphasic pulse stimulation through their DBS devices with various settings tested, including Home Settings, VIN Biphasic, and Stimulator Off, with a 30-minute washout period between conditions.
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of tremor severity and gait impairment.
What Are the Treatments Tested in This Trial?
Interventions
- Active biphasic pulse stimulation---Home Settings
- Active biphasic pulse stimulation---Stimulator Off
- Active biphasic pulse stimulation---VIN Biphasic
Active biphasic pulse stimulation---Home Settings is already approved in European Union, United States for the following indications:
- Essential Tremor
- Essential Tremor
- Parkinson's Disease
- Dystonia
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Florida
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborator
Medtronic
Industry Sponsor
Geoff Martha
Medtronic
Chief Executive Officer since 2020
Finance degree from Penn State University
Dr. Richard Kuntz
Medtronic
Chief Medical Officer since 2023
MD, MSc